Antiparasitic and antibiotic combination

This page covers all Antiparasitic and antibiotic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GABA-gated chloride channels (ivermectin); bacterial 30S ribosome (doxycycline).

Targets

GABA-gated chloride channels (ivermectin); bacterial 30S ribosome (doxycycline)

Phase 3 pipeline (1)

• Ivermectin and Doxycycline · Bangladesh Medical Research Council (BMRC) · Infectious Disease
  Ivermectin paralyzes parasites by enhancing GABA-gated chloride channel activity, while doxycycline inhibits bacterial protein synthesis; together they target parasitic and bacterial co-infections.

Patent intelligence

• antiparasitic and antibiotic combination patent landscape — aggregated cliff calendar, attackable patents, originator estates